The Health Resources and Services Administration announces the availability of $39 million for health centers in Puerto Rico, American Samoa and the U.S. Virgin Islands to expand the availability of preventive and primary healthcare services to meet immediate and anticipated Zika-related healthcare needs and enable health centers to expand services in response to other urgent and emergent primary healthcare needs.
Zika virus infection during pregnancy is a cause of microcephaly and other severe brain defects. Zika virus infection during pregnancy has also been linked to pregnancy loss and other adverse pregnancy and birth outcomes. As of October 26, 2016, more than 32,000 laboratory-confirmed cases of Zika have been reported to the Centers for Disease Control and Prevention (CDC) from the U.S. states (4,091 cases) and territories (28,723 cases).
“As Zika transmission continues, additional resources are necessary to expand health centers’ response to current and evolving Zika-related needs,” said HRSA Acting Administrator Jim Macrae. “These supplemental Zika funds will enable health centers to provide additional high-quality services to underserved populations.”
This $39 million in funding will specifically be made available for use over a three-year period to eligible Health Center Program-funded health centers in these territories.
Nearly 1,400 health centers operating over 9,800 sites provide care to more than 24 million people across this nation, in every U.S. state, the District of Columbia, Puerto Rico, the Virgin Islands and the Pacific Basin. Today, health centers employ nearly 190,000 people.
For more information on the U.S. efforts to combat the Zika virus, visit https://www.cdc.gov/zika/.
The Evolution of Health Care Environmental Hygiene: A Long Overdue Shift in Infection Control
September 5th 2024This new column, Clean Hospital with Alexandra Peters, PhD, explores advancements in health care environmental hygiene, highlighting its growing recognition as a key component of infection prevention and honoring pioneers like Professor Stephanie Dancer.
New UV-C Disinfection Technology for Ultrasound Probes Earns FDA Clearance
September 4th 2024Chronos, a chemical-free UV-C disinfection device for ultrasound probes, received FDA clearance. It offers health care professionals a fast, automated solution to reduce cross-contamination and improve infection prevention.
Addressing Sterile Processing Instrument Errors With Advanced Technology and Data Insights
September 3rd 2024Surgical instrument errors, often linked to visualization failures during sterile processing, pose significant risks to patient safety and OR efficiency. Advanced technologies, including AI, are essential for reducing these errors and improving overall outcomes in sterile processing departments.